B. Riley Securities Downgrades Gritstone Bio to Neutral, Lowers Price Target to $1
Portfolio Pulse from Benzinga Newsdesk
B. Riley Securities has downgraded Gritstone Bio from Buy to Neutral and reduced its price target from $3 to $1.
October 02, 2024 | 12:54 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
B. Riley Securities has downgraded Gritstone Bio from Buy to Neutral, significantly lowering the price target from $3 to $1. This suggests a lack of confidence in the stock's short-term performance.
The downgrade from Buy to Neutral and the significant reduction in the price target from $3 to $1 by B. Riley Securities indicates a negative outlook on Gritstone Bio's short-term performance. This is likely to lead to a decrease in investor confidence and a potential drop in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100